Health ❯Healthcare

Clinical Trials

Drug Development Phase 3 Trials Drug Efficacy Patient Outcomes Randomized Controlled Trials Research Studies Phase III Trials Cancer Research Efficacy Studies Drug Approval

Antibody Blocking SLAMF6 Restores T-Cell Attack on AML in Preclinical Study

The preclinical study points to a selective target for improving AML immunotherapy.

MBI Plus 3D Mammography More Than Doubles Cancer Detection in Dense Breasts, Trial Finds

FDA Approves Lurbinectedin Plus Atezolizumab as First-Line Maintenance for Extensive-Stage SCLC

Engineered CAR-T Cells Target PD-L1 to Deliver IL-12 at Tumors, Showing Solid-Tumor Gains in Mice

FDA Clears Tremfya for Children 6 and Older With Plaque Psoriasis and Psoriatic Arthritis

Amgen Says Repatha Reduced Cardiovascular Events in 12,000-Patient Primary-Prevention Trial

Mayo Clinic Launches Platform_Orchestrate as a Single Front Door for Faster Clinical Development

Cannabis Extract VER-01 Eases Chronic Low Back Pain in Phase 3 Trial

ACC Issues Scientific Statement on Inflammation in Heart Disease, Endorsing hsCRP for Risk Assessment

FDA Clears Novartis' Rhapsido, First Oral BTK Inhibitor for Chronic Hives

Metsera’s Obesity Drug Posts 14% Placebo-Adjusted Weight Loss, Bolstering Pfizer Buyout Case

Genmab to Buy Merus for $8 Billion to Secure Petosemtamab Cancer Drug

Phase 3 Trial in Nature Medicine Finds Cannabis-Derived Drug Eases Chronic Low Back Pain

Gene Therapy Shows 75% Slower Huntington’s Decline in Early Trial

Robotic Bronchoscopy With Cone-Beam CT Achieves 85% Diagnostic Yield in Trial

Crinetics Wins FDA Approval for Oral Acromegaly Drug Palsonify as JMP Lifts Price Target

Eupraxia Selects 8 mg Dose After Strong EoE Signals, Expands Phase 2b Trial

Preclinical Candidate AVJ16 Blocks IGF2BP1 to Halt Lung Tumor Growth in Models

TORPEdO Phase III Finds No One-Year Advantage for Proton Therapy Over IMRT in Oropharyngeal Cancer

Cochrane Review Finds RSV Vaccines Protect Older Adults and Infants Without Raising Serious Risks